Navigation Links
Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
Date:3/12/2009

NEW BRUNSWICK, N.J., March 12 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast for financial analysts on Sunday, March 15 at 10:00 a.m. (Eastern Time) to coincide with the World Institute of Pain 5th World Congress (WIP) in New York City. Phase 3 clinical data on investigational tapentadol extended release (ER), a novel centrally acting oral analgesic, will be presented for the first time in a poster session at WIP.

A pre-recorded Webcast, with the lead tapentadol researchers, will be made available concurrent to the data presentations being made during the poster session at WIP. Pre-registration is not required to view the webcast/podcast.

The presentation will provide an overview on tapentadol and review data from the following clinical posters:

  • Efficacy and Safety of Tapentadol Extended Release (ER) for Chronic Pain Due to Osteoarthritis of the Knee: Results of a Phase 3 Study

  • Efficacy and Gastrointestinal Tolerability of Tapentadol Extended Release in a Randomized, Double-Blind, Placebo- and Active-Controlled Study in Patients With Moderate-to-Severe Chronic Osteoarthritis Knee Pain

The webcast/podcast and replay can be accessed by clicking on "Webcasts/Presentations" in the Investor Relations section of the Company's website at http://www.jnj.com.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... of a new report from the Frank Hawkins Kenan Institute of Private ... business leaders, academics and policy makers identified concrete solutions at the “What’s Next, ...
(Date:1/24/2017)... ... January 24, 2017 , ... The results from the ... and particularly good news for prostate cancer patients: incidents of cancer is down as ... the report the cancer death rate has dropped from its peak of 215.1 in ...
(Date:1/24/2017)... ... January 24, 2017 , ... American Family Care (AFC) has opened a new ... care for residents in the area. The Bedford clinic will be the nineteenth location ... years by Dave Adams and Dr. Kristina Orio. Adams and Orio also independently own ...
(Date:1/24/2017)... Overland Park, KS (PRWEB) , ... January 24, ... ... rating to Premensa, a leading natural supplement for relieving premenstrual syndrome, or ... premenstrual syndrome at some point. These symptoms can include cramps, constipation, irritability, headaches, ...
(Date:1/24/2017)... ... 2017 , ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful and poignant ... understand its purpose in her life. “Who Would Have Dreamed: A Novel of Miracles” is ... love of writing. , Sharon shares that she started her spiritual journey later ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Market Research Future has a half cooked research report on Global Wound ... and expected to continue its growth by the end of 2022. ... Wound Closure ... 2019 and reaching a value of 13 billion by 2019 and 21 ... Wound Closure Device Market has been growing rapidly and is expected to ...
(Date:1/24/2017)... , Jan. 24, 2017 Market Research Future has a ... Market. The global market for Plastic Surgery & Integumentary System is ... end of the forecasted period. Market Highlights ... Global Plastic Surgery & Integumentary ... predicted that the market will reach high growth figures and thriving ...
(Date:1/24/2017)... 2017 Research and Markets has announced the ... - Product, Material - Forecast to 2025" report to their ... The ... CAGR of around 5.4% over the next decade to reach approximately ... that the market is witnessing include 3D medical printing is expected ...
Breaking Medicine Technology: